AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A
Charcot-Marie-Tooth disease 1 A (CMT1A) results from PMP22 gene duplication and is characterized by peripheral nerve myelination deficits. Here, the authors prevent the development of pathological features in a rat model of CMT1A through the local delivery of AAV2/9 expressing shRNAs against PMP22....
Guardado en:
Autores principales: | Benoit Gautier, Helene Hajjar, Sylvia Soares, Jade Berthelot, Marie Deck, Scarlette Abbou, Graham Campbell, Maria Ceprian, Sergio Gonzalez, Claire-Maëlle Fovet, Vlad Schütza, Antoine Jouvenel, Cyril Rivat, Michel Zerah, Virginie François, Caroline Le Guiner, Patrick Aubourg, Robert Fledrich, Nicolas Tricaud |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/acd3f21814e64bcbb35c0a28138116c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A
por: Suzan Boutary, et al.
Publicado: (2021) -
Isolation and characterization of maize PMP3 genes involved in salt stress tolerance.
por: Jing Fu, et al.
Publicado: (2012) -
Surgical treatment of Charcot foot with purulent infection
por: Valeriy Afanas'evich Mitish, et al.
Publicado: (2009) -
La fe que cura, Jean-Martin Charcot.
por: Ángel Cagigas
Publicado: (2001) -
Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway
por: Ruani N. Fernando, et al.
Publicado: (2016)